Hyaluronic Acid Viscosupplementation | Global | 2015 | Market Analysis
The global market for HA viscosupplementation will exhibit modest growth through 2023, driven by favorable demographic trends and the adoption of premium-priced single injection products; however, the impact of negative recommendations and poor reimbursement will limit the market to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, and Asia Pacific and Brazil across a 10-year period.